Items where Author is "Manikhas, Alexey"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Rugo, Hope S. and Barve, Abhijit and Waller, Cornelius F. and Hernandez-Bronchud, Miguel and Herson, Jay and Yuan, Jinyu and Sharma, Rajiv and Baczkowski, Mark and Kothekar, Mudgal and Loganathan, Subramanian and Manikhas, Alexey and Bondarenko, Igor and Mukhametshina, Guzel and Nemsadze, Gia and Parra, Joseph D and Abesamis Tiambeng, Maria Luisa T. and Baramidze, Kakhaber and Akewanlop, Charuwan and Vynnychenko, Ihor and Sriuranpong, Virote and Mamillapalli, Gopichand and Ray, Sirshendu and Ruiz, Eduardo P Yanez and Pennella, Eduardo (2017) Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer. A Randomized Clinical Trial. JAMA, 317 (1). pp. 37-47.

Robertson, John F R and Bondarenko, Igor M and Trishkina, Ekaterina and Dvorkin, Mikhail and Panasci, Lawrence and Manikhas, Alexey and Shparyk, Yaroslav and Cardona-Huerta, Servando and Cheung, Kwok-Leung and Philco-Salas, Manuel Jesus and Ruiz-Borrego, Manuel and Shao, Zhimin and Noguchi, Shinzaburo and Rowbottom, Jacqui and Stuart, Mary and Grinsted, Lynda M and Fazal, Mehdi and Ellis, Matthew J (2016) Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. The Lancet, 388 (10063). pp. 2997-3005. ISSN 1474-547X

Rugo, Hope S. and Barve, Abhijit and Waller, Cornelius F. and Hernandez-Bronchud, Miguel and Herson, Jay and Yuan, Jinyu and Manikhas, Alexey and Bondarenko, Igor and Mukhametshina, Guzel and Nemsadze, Gia and Parra, Joseph D. and Tiambeng, Maria Luisa T. Abesamis and Baramidze, Kakhaber and Akewanlop, Charuwan and Vynnychenko, Ihor and Sriuranpong, Virote and Manillapalli, Gopichand and Ray, Sirshendu and Ruiz, Eduardo Patricio Yanez and Pennella, Eduardo J (2016) Heritage: A phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus Herceptin. Journal of Clinical Oncology, Vol 34 (18_sup). P.-LBA503. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)

This list was generated on Thu Apr 25 02:10:02 2024 EEST.